Silverback Therapeutics, Inc.
Methods and Compositions for the Treatment of Disease with Immune Stimulatory Conjugates

Last updated:

Abstract:

Methods and conjugates are disclosed for alleviating toxicity(ies) associated with administration of immune-stimulatory conjugates, and in particular for alleviating toxicity(ies) associated with intravenous administration of such conjugates.

Status:
Application
Type:

Utility

Filling date:

11 Sep 2019

Issue date:

16 Apr 2020